Friday 30 October 2015

Transcriptomics Technologies Market Hits $6.9 Billion By 2022: Grand View Research, Inc.



The global transcriptomics technologies market is expected to reach USD 6.9 billion by 2022, according to a new report by Grand View Research Inc. The increasing demand for genetic identification and growing investment in R&D innovation along with the technological advancements across the product portfolio are the vital driving forces of this market. The increasing R&D investments are expected to highly influence biotechnological research and develop the commercialization over the forecast period. The rising investment is further anticipated to ensure positive growth and enhance business opportunities for pharmaceutical and biotechnological companies. 
Furthermore, the rising demand for efficient diagnostic methods drives the need for personalized medicines. Transcriptomics tools and the offered services identify potential drug targets, which are effective methods for diagnostic methodologies. The shifting preference of pharmaceutical companies towards therapeutics results in rising demand for the disease specific biomarker identification. This change ensures a potential opportunity in the commercialization of transcriptome research results. The escalating demand for efficient diagnostics and treatment measures in the areas of oncology, HIV, Alzheimer’s disease, etc., also contributes significantly towards transcriptomics technologies market growth. 
Further key findings from the report suggest:
  • Polymerase Chain Reaction (PCR) based transcriptomics technologies market is expected to account for over 40% market share by 2022 owing to its ability to enable amplification even from very small amounts of genetic material samples
  • Next Generation Sequencing based transcriptomics technologies market is expected to grow at a lucrative CAGR of over 17.0% over the forecast period owing to increased outsourcing of sequencing technologies, upgrading of technology enabling the analysis of cellular transcriptome from various dimensions, and wide application areas of NGS
  • North America dominates the transcriptomics technologies market in terms of revenue owing to the increasing R&D activities by the biotechnology and pharmaceutical companies
  • North America and Asia Pacific are expected to witness fastest growth of over 15.0% during the forecast period. The growth is due to the presence of untapped opportunities, rising expenditure level, and the introduction of favorable government initiatives.
  • Key players of transcriptomics technologies market include Agilent Technologies, Affymetrix, Thermo Fisher Scientific, Illumina, Life Technologies, and F. Hoffmann-La Roche
  • Market participants are constantly engaged in strategic collaborations such as mergers and acquisitions along with technological advancements in an attempt to improve presence and ensure sustainability
  • For instance, in May 2015, Agilent Technologies announced the acquisition of Cartagenia that provides services and software for clinical genetic analysis. Their products are supplied to pathology laboratories and clinical research institutes. The acquisition is expected to provide higher integration and support customer satisfaction. 
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global transcriptomics technologies market on the basis of technology, applications, and region:
Transcriptomics Technology Outlook (Revenue, USD Million, 2012 – 2022)
  • Microarray
  • PCR
  • Gene Regulation Technologies
  • Next Generation Sequencing 
Transcriptomics Technology Application (Revenue, USD Million, 2012 – 2022)
  • Clinical Diagnostics
  • Drug Discovery and Research
  • Bioinformatics
  • Comparative Transcriptomics
Transcriptomics Technologies Regional Outlook (Revenue, USD Million, 2012 – 2022)
  • North America
  • Europe
  • Asia Pacific
  • RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/


Posted by at No comments:

Thursday 29 October 2015

Liver Diseases Therapeutics Market Analysis, Growth, Trends To 2022: Grand View Research, Inc.



The global liver diseases therapeutics market is expected to reach USD 12.1 billion by 2022, according to a new report by Grand View Research Inc. The changing lifestyle habits including increasing alcohol consumption is a vital driving force of this market.
The changing dynamics in healthcare sector has heightened the importance of patients and practitioners treatment decision, which suggests that liver diseases therapeutics market is expected to witness lucrative growth over the forecast period.
Furthermore, the growing global base of geriatric population is likely to expand patient base. However, slow adoption rate of liver diseases therapeutics due to lack of clinical evidences and awareness is expected to serve as a key challenge for manufacturers. However, the incorporation of regulatory agencies along with favorable government initiatives and support will help improve usage rates.
Further key findings from the report suggest:
  • Antiviral drugs segment is expected to generate over 40.0% of the total revenue by 2022 due to the potential commercialization of GS-7977 in 2015. Moreover, the ability of this class to render safe and efficient treatment will drive segment growth over the forecast period.
  • The demand for vaccines is expected to grow at a lucrative rate of over 20.0% over the forecast period. Key factors responsible for the growth of this market include consideration of vaccines as a preventive treatment alternative for liver diseases. Increasing government initiatives towards vaccination programs for liver diseases is expected to further boost market growth
  • In 2014, North America dominated the market in terms of revenue owing to the availability of FDA-approved treatment options for liver diseases coupled with the presence of an extensive number of clinical trial studies and new product development.
  • Asia Pacific is expected to witness the fastest growth of over 8.5% over the forecast period. This growth is attributed to the wide presence of untapped needs, rising expenditure levels, and the introduction of favorable government initiatives
  • Some key players of this market include Abbott Laboratories, Astellas Pharma Inc., Bristol-Mayers Squibb, Gilead Sciences, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Novartis AG, Sanofi S.A., Pfizer Inc., Takeda Pharmaceuticals, Valeant Pharmaceuticals, and Watson Pharmaceuticals
  • Market participants are constantly engaged in developing clinical evidences in an attempt to improve presence, ensure sustainability, develop cost effective drug, and avoid barriers such as product recalls 
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the global liver diseases therapeutics market on the basis of product and region:
Liver Diseases Therapeutics Product Outlook (Revenue, USD Million, 2012 – 2022)
  • Antiviral Drugs
  • Vaccines
  • Chemotherapy
  • Targeted Therapy
  • Immunosuppressants
  • Immunoglobulins
  • Corticosteroids
Liver Diseases Therapeutics Regional Outlook (Revenue, USD Million, 2012 – 2022)
  • North America
  • Europe
  • Asia Pacific
  • RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/


Posted by at No comments:

Tuesday 27 October 2015

Medical Laser Systems Market Size, Analysis To 2022: Grand View Research, Inc.



The global medical laser systems market is expected to reach USD 12.5 billion by 2022, according to a new report by Grand View Research, Inc. Rising demand for minimal and non-invasive procedures by patients is anticipated to be the most impact rendering driver of the market.
Increasing application of these systems for diagnostic purposes, rising geriatric population base, propelling demand for cosmetic surgeries and technological advances in pre-existing laser systems are vital factors driving the demand of this market.
Medical laser systems are being prominently applied in various branches of biology such as urology, cardiology, ophthalmology etc for the purpose of diagnosis, disease management and prevention. Augmenting cases of these disorders is expected to positively impact market growth over the forecast period.
Solid state lasers are anticipated to grow at the fastest rate during the forecast period due to higher reliability, smaller compact designs, lowered cost of purchase and prolonged life span of the systems. Diode lasers are expected to hold a significant market share owing to the introduction of next generation Optically Pumped Semiconductor Lasers (OPSLs) that provide unmatched electrical efficiency.
Further key findings from the report suggest:
  • Solid state lasers are expected to grow at the fastest rate of over 10% during the forecast period due to technological advances and increasing application in diagnostic field. Neodynium Yttrium Aluminum Garnet (Nd:Yag) and Potassium titanyl phosphate (KTP) are expected to drive growth over the forecast period.
  • On the basis of application segments, urology, cardiology and gynecology are expected to be the top contributors of the medical laser systems market. Statistics provided by the WHO estimate that over 17.5 million people annually are reported with chronic cases of cardiovascular disorder that require surgical follow-up.
  • North America held over 35.0% of the market in 2014 due to rising disposable income, rising geriatric population base coupled with increasing cases of age-related disorders and conditions.
  • Asia Pacific is anticipated to witness lucrative growth and capture over 25.0% share of the global market by 2022. Rising disposal income, increasing awareness and volume of cosmetic surgeries, increasing incidences of diabetic retinopathy, rheumatoid arthritis and dental caries are key drivers for the medical laser systems market growth within the region.
  • Eminent players of this market include IRIDEX Corp., Lumenis Ltd., Syneron-Candela, Photomedex Inc., Spectranetics Corp., Biolase Inc., Bioform Medica Inc., biolitec, and Cutera.
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global medical laser systems market on the basis of products and region:
Medical Laser Systems Product Outlook (Revenue in USD Million, 2012 – 2022)
  • Diode Lasers
  • Solid State (Crystal) Lasers
    • Holmium Yttrium Aluminum Garnet (Ho:Yag) lasers
    • Erbium Yttrium Aluminum Garnet (Er:Yag) lasers
    • Neodynium Yttrium Aluminum Garnet (Nd:Yag) lasers
    • Potassium Titanyl Phosphate (KTP)
    • Alexandrite lasers
    • Ruby lasers
  • Gas Lasers
    • CO2
    • Argon
    • Krypton
    • Metal Vapor (Cu and Au)
    • Helium-Neon
    • Excimer
  • Dye Lasers
Medical Laser Systems Application Outlook (Revenue in USD Million, 2012 – 2022)
  • Dermatology
  • Ophthalmology
  • Gynecology
  • Urology
  • Dentistry
  • Cardiology
  • Others
Medical Laser Systems Regional Outlook (Revenue in USD Million, 2012 – 2022)
  • North America
  • Europe           
  • Asia Pacific
  • RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/




Posted by at No comments:
Subscribe to: Posts (Atom)